Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Seeded propagation of α-synuclein aggregation in mouse brain using protein misfolding cyclic amplification.

Nicot S, Verchère J, Bélondrade M, Mayran C, Bétemps D, Bougard D, Baron T.

FASEB J. 2019 Nov;33(11):12073-12086. doi: 10.1096/fj.201900354R. Epub 2019 Aug 1.


Lithium as a disease-modifying agent for prion diseases.

Relaño-Ginés A, Lehmann S, Brillaud E, Belondrade M, Casanova D, Hamela C, Vincent C, Poupeau S, Sarniguet J, Alvarez T, Arnaud JD, Maurel JC, Crozet C.

Transl Psychiatry. 2018 Aug 22;8(1):163. doi: 10.1038/s41398-018-0209-4.


Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification.

Bougard D, Bélondrade M, Mayran C, Bruyère-Ostells L, Lehmann S, Fournier-Wirth C, Knight RS, Will RG, Green AJE.

Emerg Infect Dis. 2018 Jul;24(7):1364-1366. doi: 10.3201/eid2407.172105.


Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.

Bougard D, Brandel JP, Bélondrade M, Béringue V, Segarra C, Fleury H, Laplanche JL, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-Wirth C, Knight R, Will R, Tiberghien P, Haïk S, Coste J.

Sci Transl Med. 2016 Dec 21;8(370):370ra182. doi: 10.1126/scitranslmed.aag1257.


Rapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies.

Belondrade M, Nicot S, Béringue V, Coste J, Lehmann S, Bougard D.

PLoS One. 2016 Jan 22;11(1):e0146833. doi: 10.1371/journal.pone.0146833. eCollection 2016.


Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

Lehmann S, Relano-Gines A, Resina S, Brillaud E, Casanova D, Vincent C, Hamela C, Poupeau S, Laffont M, Gabelle A, Delaby C, Belondrade M, Arnaud JD, Alvarez MT, Maurel JC, Maurel P, Crozet C.

PLoS One. 2014 Feb 14;9(2):e88797. doi: 10.1371/journal.pone.0088797. eCollection 2014.


Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases.

Relaño-Ginès A, Gabelle A, Hamela C, Belondrade M, Casanova D, Mourton-Gilles C, Lehmann S, Crozet C.

PLoS Pathog. 2013;9(8):e1003485. doi: 10.1371/journal.ppat.1003485. Epub 2013 Aug 1.


HEPES inhibits the conversion of prion protein in cell culture.

Delmouly K, Belondrade M, Casanova D, Milhavet O, Lehmann S.

J Gen Virol. 2011 May;92(Pt 5):1244-50. doi: 10.1099/vir.0.027334-0. Epub 2011 Feb 2.


Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.

Provansal M, Roche S, Pastore M, Casanova D, Belondrade M, Alais S, Leblanc P, Windl O, Lehmann S.

Prion. 2010 Oct-Dec;4(4):292-301. doi: 10.4161/pri.4.4.13435. Epub 2010 Oct 27.


New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment.

Lehmann S, Pastore M, Rogez-Kreuz C, Richard M, Belondrade M, Rauwel G, Durand F, Yousfi R, Criquelion J, Clayette P, Perret-Liaudet A.

J Hosp Infect. 2009 Aug;72(4):342-50. doi: 10.1016/j.jhin.2009.03.024. Epub 2009 Jun 21.


Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines.

Chasseigneaux S, Pastore M, Britton-Davidian J, Manié E, Stern MH, Callebert J, Catalan J, Casanova D, Belondrade M, Provansal M, Zhang Y, Bürkle A, Laplanche JL, Sévenet N, Lehmann S.

Arch Virol. 2008;153(9):1693-702. doi: 10.1007/s00705-008-0177-8. Epub 2008 Aug 12.


Supplemental Content

Loading ...
Support Center